// App-Quantinova.ai

2777 : Epidemiology of Bacterial Infections during Induction Chemotherapy in Adult Patients with Acute Lymphoblastic Leukemia (ALL): Analysis of the Graall-2005 Study

Researchers

Presenter

  • Emmanuelle Tavernier

Principal Investigators

  • Thibaut Leguay

  • Victoria Cacheux

  • Yves Chalandon

  • Veronique Lheritier

  • Clara Mariette

  • Faezeh Legrand

  • Denis Guyotat

  • Norbert Ifrah

  • Herve Dombret

  • Fabien Tinquaut

  • Lenaig Le Clech

  • Yosr Hicheri

  • Stephane Lepretre

  • Karin Bilger

  • Gabriela M. Baerlocher

  • Ana Berceanu

  • Maria Pilar Gallego Hernanz

Medical Centers

  • Lyon Sud University Hospital, Pierre-Benite, France

  • Pathology, Paoli-Calmettes institut, Marseilles, France

  • Hematology, Henri Becquerel Anti-Cancer Center, Rouen, France

  • Lucien Neuwirth Cancer Institute, Saint-Priest-En-Jarez, France

  • Hematology Department, Grenoble University Hospital, Grenoble, France

  • Hematology, University Hospital, Nantes, France

  • Strasbourg University, Strasbourg, France

  • Division of Rheumatology, University Hospital Geneva, Switzerland

  • Besancon University Hospital, Besancon, France

  • Hematology, University Hospital, Nantes, France

  • GRAALL Coordination, Lyon-Sud University Hospital, Pierre-Benite, France

  • Hematology, Saint-Antoine University Hospital, APHP, Paris, France

  • Clermont-Ferrand University Hospital, Clermont-Ferrand, France

  • Hematology, Poitiers Hospital, Poitiers, France

  • Rheumatology, University Hospital, Lille, France,

  • Hematology, Inselspital, Bern University Hospital, University of Bern, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland

  • Rheumatology, Montpellier University, Lapeyronie Hospital, Montpellier, France

  • Lucien Neuwirth Cancer Institute, Saint-Priest-En-Jarez, France

  • Hematology, Bordeaux University Hospital, Pessac, France

Locations

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • B-lymphocyte antigen CD20

Drug/Treatment

  • Trimethoprim/sulfamethoxazole

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Daunorubicin

  • Trimethoprim

  • Asparaginase

  • Pentamidine

  • NebuPent

  • Vincristine

  • Prednisone

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved